#
Androplex
  • Drugs A to Z
  • Androplex (Transdermal)

Androplex (Transdermal)

Generic name: testosterone (transdermal route) [ tes-TOS-ter-one ]
Drug class:Androgens and anabolic steroids

Medically reviewed by Drugs.com. Last updated on Jun 11, 2022.

Commonly used brand name(s)

In the U.S.

  • Androderm

In Canada

  • Androplex

Available Dosage Forms:

  • Patch, Extended Release

Therapeutic Class: Endocrine-Metabolic Agent

Pharmacologic Class: Androgen

Uses for Androplex

Testosterone transdermal patch is used for the treatment of males whose bodies do not make enough natural testosterone, a condition called hypogonadism. Testosterone is a male hormone responsible for the growth and development of the male sex organs and maintenance of secondary sex characteristics.

This medicine is available only with your doctor's prescription.

Before using Androplex

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of testosterone transdermal patch in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies have not been performed on the relationship of age to the effects of testosterone transdermal patch in the geriatric population. However, elderly patients may be at an increased risk for developing prostate problems, including prostate cancer, which may require caution in patients receiving testosterone transdermal patch.

Breastfeeding

Studies in women breastfeeding have demonstrated harmful infa...